ChapmanW.C., SinglaN., GenykY.A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasis. J Am Coll Surg.2007; 205(2): 256–265.
3.
WadhwaM., BirdC., DilgerP., Gaines-DasR., ThorpeR.Strategies for detection, measurement and characterization of unwanted antibodies induced by therapeutic biologicals. J Immunol Methods.2003; 278(1-2): 1–17.
4.
SchellekensH., CasadevallN.Immunogenicity of recombinant human proteins: causes and consequences. J Neurol.2004; 251(Suppl 2): II4–II9.
5.
LawsonJ.H.The clinical use and immunologic impact of thrombin in surgery. Semin Thromb Hemost.2006; 32(Suppl 1): 98–110.
